REFERENCE
FDA.FDA Drug Safety Communication: Serious allergic reactions reported with the use of Saphris (asenapine maleate). Internet Document: [2 pages], 30 Aug 2011. Available from: URL: http://www.fda.gov
Rights and permissions
About this article
Cite this article
FDA warns of asenapine hypersensitivity. React. Wkly. 1368, 2 (2011). https://doi.org/10.2165/00128415-201113680-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-201113680-00004